Topic Cancer
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Skin Cancer Back to Basics: Basal Cell Carcinoma
Price: $20.00Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JDNA0320BPublished: Mar/Apr 2020Expires: 12/31/2026DetailsRequired Passing Score: 11/15 (73%)Categories: Cancer , Dermatologic ConditionsSpecialties: OncologyTopics: Basal Cell Carcinoma , Cancer -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Data reports Largest Ever 1-year Drop in U.S. Cancer Deaths
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0220APublished: February 2020Expires: 12/31/2026Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Hematologic Childhood Cancers: An Evidence-Based Review
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: AJN1219BPublished: December 2019Expires: 12/31/2026Sources: AJN, American Journal of NursingDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Study Tracks Accelerating Use of Biomarkers in Cancer Clinical Trials
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1219Published: December 2019Expires: 12/31/2026Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Driving Change in Small Bowel Adenocarcinoma
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1119Published: November 2019Expires: 12/31/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Specialties: Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obesity-Related Cancer in Women: A Clinical Review
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: AJN0819BPublished: August 2019Expires: 12/31/2026Sources: AJN, American Journal of NursingDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ASCO Guidelines Direct Clinical Decisions for Biliary Tract Cancer
Price: $10.00Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0819Published: August 2019Expires: 12/31/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Specialties: Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cancer Pain and Quality of Life
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JHPN0419BPublished: April 2019Expires: 12/31/2026DetailsRequired Passing Score: 14/18 (77%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Talazoparib in Advanced Breast Cancer With a Germline BRCA Mutation
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0219Published: February 2019Expires: 12/31/2026Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Lenvatinib vs. Sorafenib as First-Line Treatment for Unresectable HCC
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1218Published: Dec 2018Expires: 12/31/2026Sources: Oncology TimesDetails